Back

Fitness and immune-escape within germinal centers shape premalignant evolution toward lymphoma

Zhang, L.; Hung, M. S.; Atkins, O.; Artemov, P.; Sochon, A.; Boulat, V.; Kashkar, H.; Reinhardt, H. C.; Fitzgibbon, J.; Okosun, J.; Calado, D. P.

2026-07-09 cancer biology
10.64898/2026.06.25.734549 bioRxiv
Show abstract

Germinal centers (GCs) support physiological B-cell mutagenesis and are considered lymphoma-permissive; nevertheless, lymphoma development is uncommon. Human in situ follicular neoplasia (ISFN) captures this paradox: premalignant B-cells can persist within GCs for prolonged periods without progressing to overt lymphoma. We found that human ISFN, but not normal GCs, are infiltrated by CD8 T-cells, suggesting that premalignant GC B-cells are locally immune-surveilled. Using mouse models that separate early premalignant fitness from lymphoma-associated evolution, we show that fitness-enhanced premalignant GC B-cells expand transiently but are selectively eliminated by infiltrating cytotoxic CD8 T-cells, while normal GC B-cells are spared. By contrast, evolved premalignant GC B-cells retain their fitness but disable productive CD8 T-cell cytotoxic differentiation, allowing persistence and lymphoma-like transcriptional and genomic evolution. These findings establish GCs as active immune-surveillance sites and show that progression from premalignancy to lymphoma requires both enhanced GC fitness and escape from local immune control. Key findingsGCs undergo active immune-surveillance to detect premalignant B-cells. Premalignant GC B-cells trigger cytotoxic CD8 T-cell responses. Lymphoma-associated evolution enables immune-escape within GCs. Fitness and immune-escape drive evolution from premalignancy to lymphoma. BlurbGerminal centers are considered lymphoma-permissive; however, progression from premalignancy is uncommon. Using models of human in situ follicular neoplasia, Zhang et al. demonstrate that infiltrating CD8 T-cells actively eliminate premalignant GC B-cells. Co-occurrence of lymphoma-like alterations blocks this cytotoxic T-cell response, driving immune escape and lymphoma evolution.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 9%
18.3%
2
Nature Cell Biology
118 papers in training set
Top 0.2%
9.7%
3
Nature
645 papers in training set
Top 2%
7.8%
4
Cancer Discovery
66 papers in training set
Top 0.4%
6.2%
5
Cell Reports
1498 papers in training set
Top 9%
4.3%
6
Blood
74 papers in training set
Top 0.5%
4.3%
50% of probability mass above
7
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 14%
4.0%
8
eLife
5828 papers in training set
Top 30%
4.0%
9
Journal of Experimental Medicine
119 papers in training set
Top 0.6%
4.0%
10
Nature Ecology & Evolution
18 papers in training set
Top 0.1%
2.4%
11
Cell
431 papers in training set
Top 5%
2.1%
12
The EMBO Journal
309 papers in training set
Top 3%
2.1%
13
Science Advances
1243 papers in training set
Top 17%
2.1%
14
Immunity
67 papers in training set
Top 0.9%
1.9%
15
HemaSphere
16 papers in training set
Top 0.2%
1.7%
16
Cancer Cell
42 papers in training set
Top 0.8%
1.7%
17
EMBO Reports
263 papers in training set
Top 4%
1.7%
18
Developmental Cell
196 papers in training set
Top 3%
1.1%
19
Nature Genetics
286 papers in training set
Top 4%
1.1%
20
Genes & Development
90 papers in training set
Top 1%
1.1%
21
Science
477 papers in training set
Top 7%
1.1%
22
Cancer Research
130 papers in training set
Top 3%
1.1%
23
Cell Stem Cell
62 papers in training set
Top 1%
1.0%
24
Molecular Cell
350 papers in training set
Top 4%
1.0%
25
Cell Genomics
172 papers in training set
Top 4%
0.8%
26
Nature Cancer
39 papers in training set
Top 1%
0.8%
27
PLOS Pathogens
820 papers in training set
Top 9%
0.8%
28
mBio
833 papers in training set
Top 12%
0.6%
29
Journal of Cell Biology
392 papers in training set
Top 4%
0.6%